Stanford Researchers Develop Universal Vaccine Formula Protecting Mice Against Respiratory Viruses, Bacteria, and Allergens
By
phony-account
Pulled from the oven just right. Trustworthy, fact-dense, deeply satisfying.
Summary
Stanford Medicine researchers have developed a universal vaccine formula that protects mice against a wide range of respiratory viruses, bacteria, and allergens. The intranasal vaccine represents a significant step toward a universal vaccine that could provide broad protection against multiple respiratory pathogens and allergens in a single formulation.
Key quotes
· 5 pulledIn the realm of medical advancements, a universal vaccine that can protect against any pathogen has long been a Holy Grail — and about as elusive as a mythological vessel.
Stanford Medicine researchers and collaborators have taken an astonishing step forward in that quest, surprising even themselves.
In a new study in mice, they have developed a universal vaccine formula that protects against a wide range of respiratory viruses, bacteria and even allergens.
The vaccine is delivered intranasally — such as through a nasal spray — and provides broad protection in the
Stanford Medicine researchers and their colleagues invented a new vaccine that protects mice from respiratory viruses, bacteria and allergens — the closest yet to a universal vaccine.
You might also wanna read
Columbia Researcher Discovers Rare Genetic Mutation That Provides Universal Antiviral Immunity
Columbia University immunologist Dusan Bogunovic discovered that a rare genetic mutation causing immune deficiency in some patients also gra
Experimental pill daraxonrasib extends survival in advanced pancreatic cancer patients, study finds
Researchers reported that daraxonrasib, a novel experimental pill, helped patients with advanced pancreatic cancer live longer by blocking a
Spinach-derived photosynthetic treatment shows promise for dry eye disease
Scientists at the National University of Singapore have developed an experimental treatment for dry eye disease that uses photosynthetic mac
Researchers develop phage-based preventive treatment for newborn meningitis caused by E. coli K1
Researchers from the Biozentrum, University of Basel, and ETH Zurich have developed a novel preventive treatment for newborn meningitis caus
Exploring the science behind quantum effects in healthcare: separating research from pseudoscience
The article explores the intersection of quantum physics and healthcare, distinguishing between pseudoscientific "quantum therapies" and leg
Experimental pill daraxonrasib nearly doubles survival time in advanced pancreatic cancer trial
A novel experimental pill called daraxonrasib has shown promise in extending survival for patients with advanced pancreatic cancer. The drug
